The document discusses the long-term investment potential of the healthcare sector, highlighting its resilience to economic cycles and its strong risk/return ratio. It notes the growing demand for healthcare due to aging populations and increasing prosperity in emerging markets. The document also emphasizes the high costs and potential rewards of pharmaceutical research and development.
documents/EFTA01457961.pdf
{}